中国医药,600056,收入构成,报告日期,2021-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药商业,1231358,1132791,98567,8%,27.04% 医药工业,170908,75707,95201,55.7%,26.12% 其中:中药材加工及饮片,21396,17536,3860,18.04%,1.06% 其中:制剂,117240,31494,85747,73.14%,23.52% 其中:原料药,32271,26676,5595,17.34%,1.53% 其他(补充),8255,3916,4339,52.56%,1.19% 内部抵消,-26139,-24534,-1605,6.14%,-0.44% 国际贸易,442153,369325,72828,16.47%,19.98% 中国医药,600056,收入构成,报告日期,2020-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药商业,2629344,2424594,204749,7.79%,30.11% 医药工业,393697,171925,221771,56.33%,32.62% 其他(补充),14676,6478,8198,55.86%,1.21% 内部抵消,-363113,-356301,-6812,1.88%,-1% 国际贸易,1256573,1004526,252047,20.06%,37.07% 中国医药,600056,收入构成,报告日期,2020-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 中药材加工及饮片,22478,18525,3953,17.59%,1.27% 制剂,115393,22991,92402,80.08%,29.62% 原料药,50286,45616,4671,9.29%,1.5% 医药商业,1214395,1111540,102856,8.47%,32.97% 其他业务,4948,2035,2914,58.88%,0.93% 内部抵消,-250531,-243824,-6707,2.68%,-2.15% 国际贸易,723952,612041,111910,15.46%,35.87% 中国医药,600056,收入构成,报告日期,2019-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:原料药,100562,91832,8730,8.68%,0.9% 内部抵消,-99413,-97972,-1441,1.45%,-0.15% 其中:制剂药,377756,62622,315135,83.42%,32.44% 国际贸易,744488,639458,105029,14.11%,10.81% 其他(补充),11090,4506,6584,59.37%,0.68% 医药商业,2354682,2151298,203383,8.64%,20.94% 医药工业,517636,183657,333979,64.52%,34.38% 中国医药,600056,收入构成,报告日期,2019-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 国际贸易,393593,334948,58645,14.9%,11.37% 其中:原料药,51745,47184,4561,8.81%,0.88% 医药工业,264756,82620,182136,68.79%,35.31% 其他(补充),5424,3142,2283,42.08%,0.44% 医药商业,1082645,983984,98661,9.11%,19.13% 内部抵消,-60399,-59604,-795,1.32%,-0.15% 其中:制剂,200620,30262,170357,84.92%,33.02% 中国医药,600056,收入构成,报告日期,2018-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药工业,559628,180689,378939,67.71%,58.34% 国际贸易,666950,571452,95498,14.32%,14.7% 其他(补充),27509,13347,14162,51.48%,2.18% 医药商业,1846517,1685567,160949,8.72%,24.78% 中国医药,600056,收入构成,报告日期,2018-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:制剂,204061,34436,169625,83.12%,33.42% 其中:原料药,58220,48354,9865,16.95%,1.94% 国际贸易,326037,271055,54981,16.86%,10.83% 其他(补充),8837,2921,5916,66.95%,1.17% 医药商业,886065,809246,76819,8.67%,15.14% 医药工业,283516,93126,190390,67.15%,37.51% 内部抵消,-51526,-51448,-78,0.15%,-0.02% 中国医药,600056,收入构成,报告日期,2017-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 原料药,124609,108785,15824,12.7%,3.67% 国际贸易,698807,604389,94418,13.51%,21.9% 其他(补充),19670,10715,8955,45.53%,2.08% 制剂,239966,65224,174742,72.82%,40.53% 内部抵消,-65554,-65231,-323,0.49%,-0.07% 医药商业,1992736,1855241,137495,6.9%,31.89% 中国医药,600056,收入构成,报告日期,2017-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 内部抵消,-32176,-32131,-45,0.14%,-0.02% 国际贸易,346531,295694,50837,14.67%,27.57% 医药商业,955236,891532,63703,6.67%,34.55% 医药工业,147567,81584,65983,44.71%,35.78% 其他(补充),8474,4556,3918,46.23%,2.12% 中国医药,600056,收入构成,报告日期,2016-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),11426,5345,6081,53.22%,1.16% 内部抵消,-84449,-84449,0,0%,0% 国际贸易,684293,609745,74548,10.89%,14.16% 其中:调拨,743815,721831,21985,2.96%,4.18% 其中:纯销,969585,874299,95287,9.83%,18.1% 医药商业,1713401,1596130,117271,6.84%,22.28% 其中:中成药,46,32,14,30.43%,0% 其中:化学制剂,141209,55289,85920,60.85%,16.32% 其中:原料药,107863,88168,19695,18.26%,3.74% 医药工业,249118,143489,105629,42.4%,20.07% 中国医药,600056,收入构成,报告日期,2016-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),5050,3086,1964,38.89%,0.75% 内部抵消,-40502,-40457,-46,0.11%,-0.02% 国际贸易,335849,296678,39172,11.66%,15.04% 其中:调拨,361683,347538,14145,3.91%,5.43% 其中:纯销,418793,374289,44504,10.63%,17.09% 其中:医药商业,780477,721827,58650,7.51%,22.52% 其中:中成药,8,7,1,7.54%,0% 其中:化学制剂,67379,29053,38326,56.88%,14.72% 其中:原料药,54685,41992,12693,23.21%,4.87% 医药工业,122072,71053,51019,41.79%,19.59% 中国医药,600056,收入构成,报告日期,2015-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),10287,6051,4235,41.17%,0.99% 内部抵消,-68357,-68281,-75,0.11%,-0.02% 国际贸易,678501,604595,73906,10.89%,17.36% 其中:调拨,226949,220685,6264,2.76%,1.47% 其中:纯销,980856,908938,71918,7.33%,16.89% 医药商业,1207805,1129624,78182,6.47%,18.36% 其中:中成药,2916,1930,986,33.82%,0.23% 其中:化学制剂,115222,44231,70992,61.61%,16.67% 其中:原料药,110648,86965,23683,21.4%,5.56% 医药工业,228787,133126,95660,41.81%,22.47% 中国医药,600056,收入构成,报告日期,2015-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药工业-中成药,1447,956,491,33.94%,0.38% 国际贸易,326823,281731,45092,13.8%,35.12% 其他(补充),3690,1988,1702,46.12%,1.33% 医药商业-调拨,194205,190290,3915,2.02%,3.05% 医药工业-化学制剂,57515,23577,33938,59.01%,26.43% 内部抵消,-38167,-37943,-224,0.59%,-0.17% 医药商业-纯销,353946,318371,35575,10.05%,27.71% 医药工业-原料药,51528,43629,7899,15.33%,6.15% 中国医药,600056,收入构成,报告日期,2014-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其中:中成药,2835,1839,995,35.11%,0.29% 其他(补充),7457,2940,4517,60.57%,1.31% 其中:调拨,175692,170808,4884,2.78%,1.41% 内部抵消,-34103,-34692,588,-1.72%,0.17% 其中:纯销,794441,736477,57964,7.3%,16.79% 其中:化学制剂,99711,44695,55016,55.18%,15.94% 医药工业,215554,139992,75562,35.05%,21.89% 国际贸易,626696,563428,63269,10.1%,18.33% 医药商业,970133,907285,62849,6.48%,18.21% 其中:原料药,113009,93458,19551,17.3%,5.66% 中国医药,600056,收入构成,报告日期,2014-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2339,-- ,2339,--,2.33% 内部抵消,-23326,-23224,-102,0.44%,-0.1% 国际贸易,340004,309382,30622,9.01%,30.45% 医药商业-调拨,127391,125814,1577,1.24%,1.57% 医药商业-纯销,312287,282661,29626,9.49%,29.46% 医药工业-中成药,1458,909,550,37.69%,0.55% 医药工业-化学制剂,52389,25675,26714,50.99%,26.57% 医药工业-原料药,61470,52243,9227,15.01%,9.18% 中国医药,600056,收入构成,报告日期,2013-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),4311,1546,2765,64.14%,0.9% 内部抵消,-36321,-35796,-525,1.45%,-0.17% 国际贸易,548171,481816,66355,12.1%,21.62% 其中:调拨,130974,127544,3430,2.62%,1.12% 其中:纯销,622565,570606,51959,8.35%,16.93% 医药商业,753539,698150,55389,7.35%,18.04% 其中:中成药,2458,1754,704,28.65%,0.23% 其中:化学制剂,95453,51394,44060,46.16%,14.35% 其中:原料药,115339,96307,19032,16.5%,6.2% 医药工业,213250,149454,63796,29.92%,20.78% 中国医药,600056,收入构成,报告日期,2013-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),636,-- ,636,--,0.7% 合并抵消,-16188,-16188,0,0%,0% 国际贸易,289269,253031,36238,12.53%,40% 其中:调拨,42207,41241,966,2.29%,1.07% 其中:纯销,200306,180765,19540,9.76%,21.57% 医药商业,242513,222006,20507,8.46%,22.64% 其中:制剂,12914,7543,5371,41.59%,5.93% 其中:原料药,4413,3430,983,22.28%,1.09% 医药工业,17327,10973,6354,36.67%,7.01% 中国医药,600056,收入构成,报告日期,2012-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1203,141,1061,88.24%,0.67% 内部抵消,-36540,-36540,0,0%,0% 国际贸易,573266,512291,60975,10.64%,38.65% 其中:调拨,65764,64426,1339,2.04%,0.85% 其中:纯销,352150,318350,33800,9.6%,21.43% 医药商业,417914,382776,35138,8.41%,22.27% 其中:化学制剂,24142,13542,10601,43.91%,6.72% 其中:原料药,10151,8031,2120,20.89%,1.34% 医药工业,34293,21572,12721,37.09%,8.06% 中国医药,600056,收入构成,报告日期,2012-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药商业,217624,197583,20041,9.21%,36.69% 医药工业,14478,7820,6658,45.99%,12.19% 其他(补充),309,-- ,309,--,0.56% 国际贸易,212024,184407,27617,13.03%,50.56% 中国医药,600056,收入构成,报告日期,2011-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 内部抵消,-20669,-20669,0,0%,0% 其中:调拨,28390,27241,1148,4.05%,0.87% 其中:纯销,269839,245443,24396,9.04%,18.56% 其中:化学制剂,30242,17099,13143,43.46%,10% 其中:原料药,2277,1757,519,22.82%,0.4% 其他(补充),623,174,449,72%,0.34% 国际贸易,416285,363699,52586,12.63%,40% 医药商业,298229,272684,25544,8.57%,19.43% 医药工业,32519,18856,13663,42.01%,10.39% 中国医药,600056,收入构成,报告日期,2011-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 国际贸易,156733,142125,14608,9.32%,40.89% 医药商业,151376,137807,13569,8.96%,37.98% 医药工业,19393,11843,7550,38.93%,21.13% 中国医药,600056,收入构成,报告日期,2010-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),401,120,281,70.01%,0.3% 内部抵消,-21581,-21581,0,0%,0% 国际贸易,398040,368535,29505,7.41%,31.94% 其中:调拨,23578,22792,787,3.34%,0.85% 其中:纯销,194111,176371,17739,9.14%,19.2% 医药商业,217689,199163,18526,8.51%,20.05% 其中:化学制剂,31513,18743,12770,40.52%,13.82% 医药工业,31513,18743,12770,40.52%,13.82% 中国医药,600056,收入构成,报告日期,2010-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 国际贸易,150597,137310,13287,8.82%,45.39% 医药商业,120884,111260,9624,7.96%,32.88% 医药工业,18258,11896,6362,34.85%,21.74% 中国医药,600056,收入构成,报告日期,2009-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 一般贸易,92120,82597,9523,10.34%,17.98% 工程施工,5060,4270,790,15.61%,1.49% 医药贸易,381443,338782,42661,11.18%,80.53% 中国医药,600056,收入构成,报告日期,2009-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他销售,41553,36976,4576,11.01%,19.34% 工程施工,4978,4726,252,5.06%,1.07% 医疗器械,59834,57404,2430,4.06%,10.27% 药品,104959,88560,16399,15.62%,69.32% 中国医药,600056,收入构成,报告日期,2008-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 一般贸易,73431,67241,6190,8.43%,13.84% 工程施工,10642,7586,3056,28.71%,6.83% 医药贸易,223655,188192,35464,15.86%,79.32% 中国医药,600056,收入构成,报告日期,2008-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他销售,33219,29546,3673,11.06%,21.07% 工程施工,1401,1036,365,26.04%,2.09% 医疗器械,43570,41915,1656,3.8%,9.5% 药品,66958,55218,11740,17.53%,67.34% 中国医药,600056,收入构成,报告日期,2007-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,47743,42366,5376,11.26%,17.7% 承包工程,21075,18329,2746,13.03%,9.04% 医疗器械,76331,72445,3886,5.09%,12.79% 药品药材,102285,83915,18370,17.96%,60.47% 中国医药,600056,收入构成,报告日期,2007-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他销售,31308,29579,1729,5.52%,12.39% 工程施工,1390,1031,360,25.88%,2.58% 医疗器械,30727,29041,1686,5.49%,12.08% 药品,46684,36506,10177,21.8%,72.94% 中国医药,600056,收入构成,报告日期,2006-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他商品销售,37313,35041,0,6.09%,0% 工程施工,61118,58569,0,4.17%,0% 医疗器械销售,92300,86953,0,5.79%,0% 药品销售,79593,66264,0,16.75%,0% 中国医药,600056,收入构成,报告日期,2006-09-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他销售,28079,26373,0,6.07%,0% 工程施工,1528,970,0,36.51%,0% 医疗器械,64098,60697,0,5.31%,0% 药品,77086,66041,0,14.33%,0% 中国医药,600056,收入构成,报告日期,2006-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他销售,25770,24409,0,5.28%,0% 工程施工,917,597,0,34.86%,0% 医疗器械,44597,42412,0,4.9%,0% 药品,38486,31740,0,17.53%,0% 中国医药,600056,收入构成,报告日期,2006-03-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他销售,7638,7011,0,8.2%,0% 工程施工,398,301,0,24.37%,0% 医疗器械,3757,3615,0,3.78%,0% 药品,37164,33277,0,10.46%,0% 中国医药,600056,收入构成,报告日期,2005-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他商品销售收入,27498,25644,1854,6.74%,9.14% 工程施工收入,3001,1777,1225,40.8%,6.04% 医疗器械销售收入,83011,78967,4043,4.87%,19.94% 药品销售收入,79457,66300,13157,16.56%,64.88% 中国医药,600056,收入构成,报告日期,2005-09-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他销售,21958,19902,0,9.36%,0% 工程施工,1589,858,0,46.04%,0% 医疗器械,46966,44571,0,5.1%,0% 药品,60053,51765,0,13.8%,0% 中国医药,600056,收入构成,报告日期,2005-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他商品销售收入,15764,14237,0,9.69%,0% 工程施工收入,854,499,0,41.53%,0% 医疗器械销售收入,23341,21565,0,7.61%,0% 药品销售收入,48104,42556,0,11.53%,0% 中国医药,600056,收入构成,报告日期,2005-03-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 自营进口,16261,15550,0,4.38%,0% 内贸销售,3833,2637,0,31.21%,0% 代理进口,9523,9311,0,2.23%,0% 自营出口,17359,15385,0,11.37%,0% 中国医药,600056,收入构成,报告日期,2004-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 内贸销售,7995,4845,3150,39.4%,43.35% 易货出口,7715,7329,386,5.01%,5.31% 代理出口,4019,3960,59,1.47%,0.81% 代理进口,140473,138317,2157,1.54%,29.68% 自营出口,42860,41484,1376,3.21%,18.93% 易货进口,14381,14242,139,0.97%,1.92% 中国医药,600056,收入构成,报告日期,2004-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 工程施工,670,0,315,100%,10.26% 易货出口,4508,0,226,100%,7.35% 代理出口,1536,0,59,100%,1.92% 自营出口,26177,0,704,100%,22.95% 易货进口,14381,0,139,100%,4.54% 代理进口,60973,0,1626,100%,52.97% 中国医药,600056,收入构成,报告日期,2003-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 工程施工,1498,825,0,44.94%,0% 内贸收入,36,35,0,4.37%,0% 代理出口,4282,4185,0,2.26%,0% 自营出口,32116,30757,0,4.23%,0% 自营进口,88,83,0,5.77%,0% 易货进口,6707,6657,0,0.74%,0% 代理进口,222343,220386,0,0.88%,0% 中国医药,600056,收入构成,报告日期,2003-09-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 工程施工,653,349,304,46.55%,11.02% 内贸销售,36,35,2,4.37%,0.06% 易货代理出口,6657,6657,0,0%,0% 代理出口销售,3000,2906,94,3.13%,3.4% 自营出口销售,13316,12710,605,4.54%,21.94% 自营进口销售,88,83,5,5.77%,0.18% 代理进口销售,184910,183161,1749,0.95%,63.4% 中国医药,600056,收入构成,报告日期,2003-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理出口销售,1148,1114,0,2.92%,0% 自营出口销售,13322,12559,0,5.72%,0% 工程施工,432,200,0,53.64%,0% 自营进口销售,88,83,0,5.77%,0% 代理进口销售,147678,146354,0,0.9%,0% 中国医药,600056,收入构成,报告日期,2003-03-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 工程施工,80,47,34,42.08%,3.93% 代理出口销售,215,192,23,10.63%,2.66% 自营出口销售,1695,1512,183,10.79%,21.25% 自营进口销售,88,83,5,5.77%,0.59% 代理进口销售,74599,73983,616,0.83%,71.58%